Rosoux, A <br/><br/>
Effectiveness of crizotinib in a patient with ALK IHC-positive/FISH-negative metastatic lung adenocarcinoma.  [electronic resource] 

 -  Lung cancer (Amsterdam, Netherlands)  08 2016 
 - 118-121 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1872-8332 
<br/><br/><label>Standard No.: </label>10.1016/j.lungcan.2016.06.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--diagnosis<br/>Adenocarcinoma of Lung<br/>Adult<br/>Anaplastic Lymphoma Kinase<br/>Antineoplastic Agents--therapeutic use<br/>Crizotinib<br/>Fatal Outcome<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>In Situ Hybridization, Fluorescence<br/>Lung Neoplasms--diagnosis<br/>Neoplasm Metastasis<br/>Neoplasm Staging<br/>Protein Kinase Inhibitors--therapeutic use<br/>Pyrazoles--therapeutic use<br/>Pyridines--therapeutic use<br/>Receptor Protein-Tyrosine Kinases--genetics